Skip to main content
. 1999 Jun;37(6):1676–1682. doi: 10.1128/jcm.37.6.1676-1682.1999

TABLE 1.

Suggested broth microdilution breakpoints for rapidly growing mycobacteriaa

Drug MIC (μg/ml) for category:
Susceptible Intermediate Resistant
Amikacinb ≤16 32 ≥64
Cefoxitin ≤16 32 [32–64] ≥64 [≥128]
Ciprofloxacinb ≤1 2 ≥4
Clarithromycinb ≤2 4 ≥8
Doxycycline ≤1 2–8 ≥16
Imipenemb ≤4 8 ≥16
Sulfamethoxazolebc ≤32 ≥64
Tobramycin (M. chelonae only) ≤4 8 ≥16
a

Breakpoints recommended by the American Society for Microbiology Clinical Procedures Handbook (3). Proposed new breakpoints are in brackets. 

b

NCCLS recommended breakpoint for bacteria that grow aerobically (8a). 

c

NCCLS recommendations are for trimethoprim-sulfamethoxazole at similar but not identical concentrations.